Comment from Charlotte Lozier Institute

Summary: The Charlotte Lozier Institute, a research and education institute of Susan B. Anthony Pro-Life America, opposes the citizen petition requesting that the FDA take no action to reduce patient access to mifepristone. They argue that the FDA should instead strengthen the mifepristone Risk Evaluation and Mitigation Strategy (REMS) by restoring previous safeguards, such as in-person prescribing, to ensure patient safety and prevent coercion.